395 related articles for article (PubMed ID: 21944136)
1. Complications after prostate biopsy: data from SEER-Medicare.
Loeb S; Carter HB; Berndt SI; Ricker W; Schaeffer EM
J Urol; 2011 Nov; 186(5):1830-4. PubMed ID: 21944136
[TBL] [Abstract][Full Text] [Related]
2. Is repeat prostate biopsy associated with a greater risk of hospitalization? Data from SEER-Medicare.
Loeb S; Carter HB; Berndt SI; Ricker W; Schaeffer EM
J Urol; 2013 Mar; 189(3):867-70. PubMed ID: 23063634
[TBL] [Abstract][Full Text] [Related]
3. Commentary on "Is repeat prostate biopsy associated with a greater risk of hospitalization? Data from SEER-Medicare." Loeb S, Carter HB, Berndt SI, Ricker W, Schaeffer EM, Department of Urology, New York University, New York, NY. J Urol 2013; 189(3):867-70. [Epub 2012 Oct 9]. doi: 10.1016/j.juro.2012.10.005.
Eggener S
Urol Oncol; 2014 Aug; 32(6):935-6. PubMed ID: 25087672
[TBL] [Abstract][Full Text] [Related]
4. Infectious complications and hospital admissions after prostate biopsy in a European randomized trial.
Loeb S; van den Heuvel S; Zhu X; Bangma CH; Schröder FH; Roobol MJ
Eur Urol; 2012 Jun; 61(6):1110-4. PubMed ID: 22244150
[TBL] [Abstract][Full Text] [Related]
5. Re: Complications after prostate biopsy: data from SEER-Medicare: S. Loeb, H. B. Carter, S. I. Berndt, W. Ricker and E. M. Schaeffer J Urol 2011; 186: 1830-1834.
Ravi P; Sammon J; Meskawi M; Sun M; Karakiewicz PI; Trinh QD
J Urol; 2012 Aug; 188(2):677-8. PubMed ID: 22704450
[No Abstract] [Full Text] [Related]
6. Detection of prostate cancer via biopsy in the Medicare-SEER population during the PSA era.
Welch HG; Fisher ES; Gottlieb DJ; Barry MJ
J Natl Cancer Inst; 2007 Sep; 99(18):1395-400. PubMed ID: 17848671
[TBL] [Abstract][Full Text] [Related]
7. The impact of repeat biopsies on infectious complications in men with prostate cancer on active surveillance.
Ehdaie B; Vertosick E; Spaliviero M; Giallo-Uvino A; Taur Y; O'Sullivan M; Livingston J; Sogani P; Eastham J; Scardino P; Touijer K
J Urol; 2014 Mar; 191(3):660-4. PubMed ID: 24018237
[TBL] [Abstract][Full Text] [Related]
8. To biopsy or not to biopsy: minimizing the risk of prostate needle biopsy.
Kibel AS
J Urol; 2013 Mar; 189(3):796-7. PubMed ID: 23246850
[No Abstract] [Full Text] [Related]
9. Indications, Utilization and Complications Following Prostate Biopsy: New York State Analysis.
Halpern JA; Sedrakyan A; Dinerman B; Hsu WC; Mao J; Hu JC
J Urol; 2017 Apr; 197(4):1020-1025. PubMed ID: 27856226
[TBL] [Abstract][Full Text] [Related]
10. Re: To biopsy or not to biopsy: minimizing the risk of prostate needle biopsy: A. S. Kibel J Urol 2013; 189: 796-797.
Horan AH
J Urol; 2013 Sep; 190(3):1139. PubMed ID: 23583228
[No Abstract] [Full Text] [Related]
11. Re: Is repeat prostate biopsy associated with a greater risk of hospitalization? Data from SEER-Medicare: S. Loeb, H. B. Carter, S. I. Berndt, W. Ricker and E. M. Schaeffer J Urol 2013; 189: 867-870.
Singh I; Gautam L
J Urol; 2013 Oct; 190(4):1439-40. PubMed ID: 23886882
[No Abstract] [Full Text] [Related]
12. Predictors of Infectious Complications after Targeted Prophylaxis for Prostate Needle Biopsy.
Papagiannopoulos D; Abern M; Wilson N; O'Block N; Raff L; Coogan C; Latchamsetty KC
J Urol; 2018 Jan; 199(1):155-160. PubMed ID: 28807644
[TBL] [Abstract][Full Text] [Related]
13. The role of increasing detection in the rising incidence of prostate cancer.
Potosky AL; Miller BA; Albertsen PC; Kramer BS
JAMA; 1995 Feb; 273(7):548-52. PubMed ID: 7530782
[TBL] [Abstract][Full Text] [Related]
14. Gonadotropin-releasing hormone agonist use in men without a cancer registry diagnosis of prostate cancer.
Kuo YF; Goodwin JS; Shahinian VB
BMC Health Serv Res; 2008 Jul; 8():146. PubMed ID: 18620606
[TBL] [Abstract][Full Text] [Related]
15. Reply by author.
J Urol; 2013 Sep; 190(3):1140. PubMed ID: 23770372
[No Abstract] [Full Text] [Related]
16. Racial Differences in the Surgical Care of Medicare Beneficiaries With Localized Prostate Cancer.
Schmid M; Meyer CP; Reznor G; Choueiri TK; Hanske J; Sammon JD; Abdollah F; Chun FK; Kibel AS; Tucker-Seeley RD; Kantoff PW; Lipsitz SR; Menon M; Nguyen PL; Trinh QD
JAMA Oncol; 2016 Jan; 2(1):85-93. PubMed ID: 26502115
[TBL] [Abstract][Full Text] [Related]
17. Ascertainment of postprostatectomy radiotherapy for prostate cancer in the Surveillance, Epidemiology, and End Results database.
Wang K; Sheets NC; Basak R; Chen RC
Cancer; 2016 Oct; 122(19):3069-74. PubMed ID: 27352280
[TBL] [Abstract][Full Text] [Related]
18. Risk Factors for Infection after Prostate Biopsy in the United States.
Shoag JE; Gaffney C; Pantuck M; Sun T; Gorin M; Schaeffer E; Sedrakyan A; Vickers A; Hu J
Urology; 2020 Apr; 138():113-118. PubMed ID: 31899233
[TBL] [Abstract][Full Text] [Related]
19. The cost implications of prostate cancer screening in the Medicare population.
Ma X; Wang R; Long JB; Ross JS; Soulos PR; Yu JB; Makarov DV; Gold HT; Gross CP
Cancer; 2014 Jan; 120(1):96-102. PubMed ID: 24122801
[TBL] [Abstract][Full Text] [Related]
20. Complications following prostate needle biopsy requiring hospital admission or emergency department visits - experience from 1000 consecutive cases.
Pinkhasov GI; Lin YK; Palmerola R; Smith P; Mahon F; Kaag MG; Dagen JE; Harpster LE; Reese CT; Raman JD
BJU Int; 2012 Aug; 110(3):369-74. PubMed ID: 22313996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
